A Weekly Injection Could Replace Painful Daily Treatment for Rare Fat Disorder
A diabetes drug may beat costly shots for patients with a rare genetic condition, according to a Rutgers Health study.
Hosted on MSN1mon
The Zepbound Shortage Is Over — Here's What to Expect if You've Been Using an Off-Brand Version
"FDA has determined that the shortage of tirzepatide injection products, which first began in December 2022, is resolved," the agency said, per CNBC. "FDA continues to monitor supply and demand ...
Healthline6d
Mounjaro Injection Overview
Mounjaro (tirzepatide) is a prescription drug used to help manage blood sugar levels in adults with type 2 diabetes. Mounjaro comes as an injection that’s given under your skin. This medication ...
Healthline24d
Dosage for Mounjaro: What You Need to Know
Mounjaro (tirzepatide) is a prescription drug that’s used to treat type 2 diabetes. The drug comes as a liquid solution that you inject under your skin, typically once per week. Mounjaro ...
Telegraph & Argus29d
NHS Mounjaro - what is it and who will be eligible?
Weight-loss injection Mounjaro, also known as tirzepatide, will be rolled out on the NHS gradually over a 12-year period, starting this year, but many eligible patients will have to wait.
Benzinga.com27d
Eli Lilly Joins FDA Lawsuit Over Compounded Obesity Drugs, Seeks 'Swift End' And 'To Protect Its Interests'
Eli Lilly intervenes in lawsuit to defend FDA's shortage determination of tirzepatide injections, branded as Mounjaro and Zepbound. FDA allows compounding of tirzepatide injections until February ...
JD Supra27d
FDA Announced Removal of Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a declaratory order determining that the shortage of diabetes and weight-loss tirzepatide injection products (Mounjaro and ...